Screening and Surveillance of Barrett's Esophagus

被引：0

作者：

Regula, Jaroslaw ^{[1
,2
,3
]}

机构：

[1] Med Ctr Postgraduate Educ, Dept Gastroenterol, Warsaw, Poland

[2] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland

[3] Inst Oncol, Warsaw, Poland

来源：

DIGESTIVE DISEASES | 2009年 / 27卷 / 01期

关键词：

Barrett's esophagus; Surveillance; Screening; Cost-effectiveness; HIGH-GRADE DYSPLASIA; ENDOSCOPIC SURVEILLANCE; CANCER-RISK; ADENOCARCINOMA; GUIDELINES; DIAGNOSIS;

D O I：

10.1159/000210104

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Screening and surveillance of Barrett's esophagus is a matter of discussion in the current world literature due to uncertainties concerning its cost-effectiveness. Important and valid arguments for and against it are available. Despite the fact that this issue is still to be resolved, screening using standard gastroscopy once in a lifetime and surveillance using repeated endoscopies with multiple blind biopsies are widely practiced by individual gastroenterologists. Further studies that mainly focus on finding better predictors of progression to cancer are needed to be able to prepare clear and useful guidelines. The ultimate aim of screening and surveillance should be decrease in mortality from esophageal adenocarcinoma resulting from Barrett's esophagus. Copyright (C) 2009 S. Karger AG, Basel

引用

收藏

页码：54 / 57

页数：4

相关论文

共 19 条

[1] Current practice compared with the international guidelines: endoscopic surveillance of Barrett's esophagus [J].

Amamra, Nassira ;

Touzet, Sandrine ;

Colin, Cyrille ;

Ponchon, Thierry .

JOURNAL OF EVALUATION IN CLINICAL PRACTICE, 2007, 13 (05) :789-794

[2] Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma [J].

Buttar, NS ;

Wang, KK ;

Sebo, TJ ;

Riehle, DM ;

Krishnadath, KK ;

Lutzke, LS ;

Anderson, MA ;

Petterson, TM ;

Burgart, LJ .

GASTROENTEROLOGY, 2001, 120 (07) :1630-1639

[3] Surveillance and survival in Barrett's adenocarcinomas: A population-based studyd [J].

Corley, DA ;

Levin, TR ;

Habel, LA ;

Weiss, NS ;

Buffler, PA .

GASTROENTEROLOGY, 2002, 122 (03) :633-640

[4] Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus [J].

Hennig, Ewa E. ;

Mikula, Michal ;

Orlowska, Janina ;

Jarosz, Dorota ;

Bielasik, Andrzej ;

Regula, Jaroslaw ;

Ostrowski, Jerzy .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2008, 86 (02) :233-242

[5] Screening and surveillance for Barrett esophagus in high-risk groups: A cost-utility analysis [J].

Inadomi, JM ;

Sampliner, R ;

Lagergren, J ;

Lieberman, D ;

Fendrick, AM ;

Vakil, N .

ANNALS OF INTERNAL MEDICINE, 2003, 138 (03) :176-186

[6] Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study [J].

Macdonald, CE ;

Wicks, AC ;

Playford, RJ .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7271) :1252-1255

[7] Molecular defense mechanisms of Barrett's metaplasia estimated by an integrative genomics [J].

Ostrowski, Jerzy ;

Mikula, Michal ;

Karczmarski, Jakub ;

Rubel, Tyrnon ;

Wyrwicz, Lucjan S. ;

Bragoszewski, Piotr ;

Gaj, Pawel ;

Dadlez, Michal ;

Butruk, Eugeniusz ;

Regula, Jaroslaw .

JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (07) :733-743

[8]

Provenzale D, 1999, AM J GASTROENTEROL, V94, P2043

[9] Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets [J].

Reid, BJ ;

Levine, DS ;

Longton, G ;

Blount, PL ;

Rabinovitch, PS .

AMERICAN JOURNAL OF GASTROENTEROLOGY, 2000, 95 (07) :1669-1676

[10] Leukocyte telomere length predicts cancer risk in Barrett's esophagus [J].

Risques, Rosa Ana ;

Vaughan, Thomas L. ;

Li, Xiaohong ;

Odze, Robert D. ;

Blount, Patricia L. ;

Ayub, Kamran ;

Gallaher, Jasmine L. ;

Reid, Brian J. ;

Rabinovitch, Peter S. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (12) :2649-2655